ALRT Technologies to Acquire CGM Medical Tech for $45M & 200M Shares, Over 4x Its Market Cap
ALRTF has more than doubled off its 52-week low of $0.001.
Summary
ALR Technologies announced a Letter of Intent to acquire CGM Medical Technology for US$45 million in cash and 200 million of its ordinary shares. This acquisition, valued at approximately $48.5 million, is over four times ALRT's current market capitalization, making it a highly transformative and financially significant event. The deal aims to vertically integrate ALRT, giving it ownership of intellectual property and manufacturing for its continuous glucose monitoring (CGM) products, which could improve margins and product control. However, the substantial cash obligation and significant share dilution (200 million shares) introduce considerable financial risk, especially given the company's recent 20-F filing that raised substantial doubt about its ability to continue as a going concern. Definitive agreements are anticipated by July 31, 2026, for the Singapore entity and August 31, 2026, for the Shenzhen entity.
At the time of this announcement, ALRTF was trading at $0.02 on OTC in the Life Sciences sector, with a market capitalization of approximately $11.3M. The 52-week trading range was $0.00 to $0.03. This news item was assessed with neutral market sentiment and an importance score of 9 out of 10. Source: PR Newswire.